This story has been updated from a previous version.

NEW YORK, May 17 - Lion Bioscience has licensed its SRS platform to Affymetrix for use in internal R&D as well as for a customer portal, Lion said Thursday.

The licensing deal will be for three years, Jan Mous, chief scientific officer of Lion, told GenomeWeb. No other terms of the agreement were disclosed, though Mous did call the size of the deal  "larger than usual" for Lion.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Women with breast or ovarian cancer living in medically underserved regions of the US are less likely to get recommended BRCA1 or BRCA2 genetic testing, according to a new study.

Three immunology researchers are to receive this year's Albany Medical Center Prize in Medicine and Biomedical Research, the Albany Times-Union reports.

In Genome Research this week: clonal evolution analysis of acute myeloid leukemia, computational pipeline to examine relationships between bacterial pathogens, and more.

Elephants may have "re-animated" a pseudogene to help stave off cancer, according to the New York Times.